Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line

Robin A. Roberts, Anne E Cress, William S. Dalton

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Incubation of human carcinoma cells with mitoxantrone resulted in an intracellular distribution of the drug into cytoplasmic, nuclear and cytoskeletal compartments occurring within 1 min of drug treatment. Incubation of the cells in drug-free medium resulted in an efflux of the drug such that 80% of the intracellular drug was eliminated from the cells by 72 hr. Approximately 20% of the initial intracellular drug concentration remained in the cells after the drug had been removed from the medium. The majority of the persistent intracellular drug was associated with soluble cytoplasmic proteins and fractions enriched in nucleic acid. Approximately 10% of the persistent drug binding was associated with cellular structures that had been depleted of soluble cytoplasmic protein and nucleic acid. During the persistent drug binding, the cells enlarged at least 2-fold as determined by microscopic examination. An increasing percentage of the cells was also observed to contain a DNA content consistent with a G2 cell cycle arrest. Taken together, these data suggest that the persistent intracellular binding of mitoxantrone results in a G2 cell cycle arrest and cellular damage.

Original languageEnglish (US)
Pages (from-to)4283-4290
Number of pages8
JournalBiochemical Pharmacology
Volume38
Issue number23
DOIs
StatePublished - Dec 1 1989

Fingerprint

Mitoxantrone
Colon
Cells
Carcinoma
Cell Line
Pharmaceutical Preparations
G2 Phase Cell Cycle Checkpoints
Nucleic Acids
Drug therapy
Cellular Structures
Microscopic examination
Proteins

ASJC Scopus subject areas

  • Pharmacology

Cite this

Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. / Roberts, Robin A.; Cress, Anne E; Dalton, William S.

In: Biochemical Pharmacology, Vol. 38, No. 23, 01.12.1989, p. 4283-4290.

Research output: Contribution to journalArticle

Roberts, Robin A. ; Cress, Anne E ; Dalton, William S. / Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. In: Biochemical Pharmacology. 1989 ; Vol. 38, No. 23. pp. 4283-4290.
@article{7317a1a87e3d4eed9d68bf67849c9dea,
title = "Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line",
abstract = "Incubation of human carcinoma cells with mitoxantrone resulted in an intracellular distribution of the drug into cytoplasmic, nuclear and cytoskeletal compartments occurring within 1 min of drug treatment. Incubation of the cells in drug-free medium resulted in an efflux of the drug such that 80{\%} of the intracellular drug was eliminated from the cells by 72 hr. Approximately 20{\%} of the initial intracellular drug concentration remained in the cells after the drug had been removed from the medium. The majority of the persistent intracellular drug was associated with soluble cytoplasmic proteins and fractions enriched in nucleic acid. Approximately 10{\%} of the persistent drug binding was associated with cellular structures that had been depleted of soluble cytoplasmic protein and nucleic acid. During the persistent drug binding, the cells enlarged at least 2-fold as determined by microscopic examination. An increasing percentage of the cells was also observed to contain a DNA content consistent with a G2 cell cycle arrest. Taken together, these data suggest that the persistent intracellular binding of mitoxantrone results in a G2 cell cycle arrest and cellular damage.",
author = "Roberts, {Robin A.} and Cress, {Anne E} and Dalton, {William S.}",
year = "1989",
month = "12",
day = "1",
doi = "10.1016/0006-2952(89)90527-3",
language = "English (US)",
volume = "38",
pages = "4283--4290",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line

AU - Roberts, Robin A.

AU - Cress, Anne E

AU - Dalton, William S.

PY - 1989/12/1

Y1 - 1989/12/1

N2 - Incubation of human carcinoma cells with mitoxantrone resulted in an intracellular distribution of the drug into cytoplasmic, nuclear and cytoskeletal compartments occurring within 1 min of drug treatment. Incubation of the cells in drug-free medium resulted in an efflux of the drug such that 80% of the intracellular drug was eliminated from the cells by 72 hr. Approximately 20% of the initial intracellular drug concentration remained in the cells after the drug had been removed from the medium. The majority of the persistent intracellular drug was associated with soluble cytoplasmic proteins and fractions enriched in nucleic acid. Approximately 10% of the persistent drug binding was associated with cellular structures that had been depleted of soluble cytoplasmic protein and nucleic acid. During the persistent drug binding, the cells enlarged at least 2-fold as determined by microscopic examination. An increasing percentage of the cells was also observed to contain a DNA content consistent with a G2 cell cycle arrest. Taken together, these data suggest that the persistent intracellular binding of mitoxantrone results in a G2 cell cycle arrest and cellular damage.

AB - Incubation of human carcinoma cells with mitoxantrone resulted in an intracellular distribution of the drug into cytoplasmic, nuclear and cytoskeletal compartments occurring within 1 min of drug treatment. Incubation of the cells in drug-free medium resulted in an efflux of the drug such that 80% of the intracellular drug was eliminated from the cells by 72 hr. Approximately 20% of the initial intracellular drug concentration remained in the cells after the drug had been removed from the medium. The majority of the persistent intracellular drug was associated with soluble cytoplasmic proteins and fractions enriched in nucleic acid. Approximately 10% of the persistent drug binding was associated with cellular structures that had been depleted of soluble cytoplasmic protein and nucleic acid. During the persistent drug binding, the cells enlarged at least 2-fold as determined by microscopic examination. An increasing percentage of the cells was also observed to contain a DNA content consistent with a G2 cell cycle arrest. Taken together, these data suggest that the persistent intracellular binding of mitoxantrone results in a G2 cell cycle arrest and cellular damage.

UR - http://www.scopus.com/inward/record.url?scp=0024317049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024317049&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(89)90527-3

DO - 10.1016/0006-2952(89)90527-3

M3 - Article

C2 - 2597200

AN - SCOPUS:0024317049

VL - 38

SP - 4283

EP - 4290

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 23

ER -